These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38546190)

  • 41. Comparison of recovery index of rocuronium or vecuronium with simultaneously administered pancuronium in the isolated forearm.
    Fawcett WJ; Fauvel NJ; Feldman SA
    Anaesthesia; 1993 Mar; 48(3):200-1. PubMed ID: 8096371
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of haemodynamic effects of rocuronium bromide with those of vecuronium in patients undergoing CABG surgery.
    Nitschmann P; Oberkogler W; Hertsig M; Schwarz S
    Eur J Anaesthesiol Suppl; 1994; 9():113-5. PubMed ID: 7925201
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Fading responses in the evoked EMG after rocuronium in cats.
    Shiraishi H; Suzuki H; Suzuki T; Katsumata N; Ogawa S
    Can J Anaesth; 1992 Dec; 39(10):1099-104. PubMed ID: 1361162
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Histamine-release haemodynamic changes produced by rocuronium, vecuronium, mivacurium, atracurium and tubocurarine.
    Naguib M; Samarkandi AH; Bakhamees HS; Magboul MA; el-Bakry AK
    Br J Anaesth; 1995 Nov; 75(5):588-92. PubMed ID: 7577286
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Newer neuromuscular blocking agents: how do they compare with established agents?
    Sparr HJ; Beaufort TM; Fuchs-Buder T
    Drugs; 2001; 61(7):919-42. PubMed ID: 11434449
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comparative study of the dose-response and time course of action of rocuronium and vecuronium in anesthetized adult patients.
    Xue FS; Liao X; Liu JH; Tong SY; Zhang YM; Zhang RJ; An G; Luo LK
    J Clin Anesth; 1998 Aug; 10(5):410-5. PubMed ID: 9702623
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of isoflurane on the actions of neuromuscular blockers on the muscle nicotine acetylcholine receptors.
    Li C; Yao S; Nie H; Lü B
    J Huazhong Univ Sci Technolog Med Sci; 2004; 24(6):605-6, 614. PubMed ID: 15791855
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Update on newer neuromuscular blocking drugs.
    Holm H; Ostergaard D
    Ann Acad Med Singap; 1994 Nov; 23(6 Suppl):108-13. PubMed ID: 7710219
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Safety and tolerability of single intravenous doses of sugammadex administered simultaneously with rocuronium or vecuronium in healthy volunteers.
    Cammu G; De Kam PJ; Demeyer I; Decoopman M; Peeters PA; Smeets JM; Foubert L
    Br J Anaesth; 2008 Mar; 100(3):373-9. PubMed ID: 18238834
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A comparison of the pharmacodynamics of rocuronium and vecuronium during halothane anaesthesia.
    Booth MG; Marsh B; Bryden FM; Robertson EN; Baird WL
    Anaesthesia; 1992 Oct; 47(10):832-4. PubMed ID: 1359803
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A randomized, dose-response study of sugammadex given for the reversal of deep rocuronium- or vecuronium-induced neuromuscular blockade under sevoflurane anesthesia.
    Duvaldestin P; Kuizenga K; Saldien V; Claudius C; Servin F; Klein J; Debaene B; Heeringa M
    Anesth Analg; 2010 Jan; 110(1):74-82. PubMed ID: 19933538
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Efficacy and safety of sugammadex (Org 25969) in reversing moderate neuromuscular block induced by rocuronium or vecuronium in Japanese patients].
    Takeda J; Iwasaki H; Yamakage M; Ozaki M; Kawamata M; Hatano Y; Yorozuya T; Miyakawa H; Kanmura Y
    Masui; 2014 Oct; 63(10):1075-82. PubMed ID: 25693332
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cardiovascular effects of an intubating dose of rocuronium 0.6 mg kg-1 in anaesthetized patients, paralysed with vecuronium.
    Wierda JM; Schuringa M; van den Broek L
    Br J Anaesth; 1997 May; 78(5):586-7. PubMed ID: 9175978
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Rocuronium vs vecuronium for neuromuscular block during transsternal thymectomy in the patient with myasthenia gravis].
    Cordero Escobar I
    Rev Esp Anestesiol Reanim; 2011 Dec; 58(10):578-82. PubMed ID: 22263401
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Efficacy and safety of sugammadex (Org 25969) in reversing deep neuromuscular block induced by rocuronium or vecuronium in Japanese patients].
    Takeda J; Iwasaki H; Otagiri T; Katoh T; Shingu K; Obara H; Nakatsuka H; Tomiyama Y; Kasaba T
    Masui; 2014 Oct; 63(10):1083-8. PubMed ID: 25693333
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The effects of age on onset and recovery from atracurium, rocuronium and vecuronium blockade].
    de Almeida MC; Latorre F; Gervais HW; Kleeman PP
    Anaesthesist; 1996 Oct; 45(10):903-6. PubMed ID: 8992904
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rocuronium and vecuronium.
    Parr MJ; Manara AR
    Br J Anaesth; 1997 Mar; 78(3):342. PubMed ID: 9135327
    [No Abstract]   [Full Text] [Related]  

  • 58. The effect of priming with vecuronium and rocuronium on young and elderly patients.
    Aziz L; Jahangir SM; Choudhury SN; Rahman K; Ohta Y; Hirakawa M
    Anesth Analg; 1997 Sep; 85(3):663-6. PubMed ID: 9296427
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Neuromuscular blocking effects of Org 9426 (rocuronium bromide); a comparative study with vecuronium bromide in Japanese patients].
    Shingu K; Masuzawa M; Omote K; Namiki A; Kikuchi H; Kawamada M; Sato S; Kimura T; Hatano N; Nakatsuka H; Morita K; Hara T; Kanmura Y; Takeda J
    Masui; 2006 Sep; 55(9):1140-8. PubMed ID: 16984012
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Onset/offset characteristics and intubating conditions of rapacuronium: a comparison with rocuronium.
    Zhou TJ; White PF; Chiu JW; Joshi GP; Dullye KK; Duffy LL; Tongier WK
    Br J Anaesth; 2000 Aug; 85(2):246-50. PubMed ID: 10992833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.